119 related articles for article (PubMed ID: 1437717)
1. Synthesis and biological activity of novel C-terminal-extended and biotinylated growth hormone-releasing factor (GRF) analogs.
Campbell RM; Lee Y; Mowles TF; McIntyre KW; Ahmad M; Felix AM; Heimer EP
Peptides; 1992; 13(4):787-93. PubMed ID: 1437717
[TBL] [Abstract][Full Text] [Related]
2. Pegylated peptides. V. Carboxy-terminal PEGylated analogs of growth hormone-releasing factor (GRF) display enhanced duration of biological activity in vivo.
Campbell RM; Heimer EP; Ahmad M; Eisenbeis HG; Lambros TJ; Lee Y; Miller RW; Stricker PR; Felix AM
J Pept Res; 1997 Jun; 49(6):527-37. PubMed ID: 9266480
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone-releasing hormone (GRF) analogs, bovine and rat GRF on growth hormone secretion in cattle in vivo.
Hashizume T; Ohtsuki K; Sasaki K; Yanagimoto M; Masuda H; Hirata T; Ohashi S
Endocr J; 1997 Dec; 44(6):811-7. PubMed ID: 9622296
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone (GH)-releasing hormone and its analogs on GH secretion from cultured adenohypophysial cells in cattle.
Soliman EB; Hashizume T; Ohashi S; Kanematsu S
Domest Anim Endocrinol; 1997 Jan; 14(1):39-46. PubMed ID: 8985668
[TBL] [Abstract][Full Text] [Related]
5. Synthetic analogs of growth hormone-releasing factor with antagonistic activity in vitro.
Sato K; Hotta M; Kageyama J; Hu HY; Dong MH; Ling N
Biochem Biophys Res Commun; 1990 Feb; 167(1):360-6. PubMed ID: 2106886
[TBL] [Abstract][Full Text] [Related]
6. Position 2 and position 2/Ala15-substituted analogs of bovine growth hormone-releasing factor (bGRF) with enhanced metabolic stability and improved in vivo bioactivity.
Kubiak TM; Friedman AR; Martin RA; Ichhpurani AK; Alaniz GR; Claflin WH; Goodwin MC; Cleary DL; Kelly CR; Hillman RM
J Med Chem; 1993 Apr; 36(7):888-97. PubMed ID: 8464043
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor.
Ling N; Baird A; Wehrenberg WB; Ueno N; Munegumi T; Brazeau P
Biochem Biophys Res Commun; 1984 Sep; 123(2):854-61. PubMed ID: 6435620
[TBL] [Abstract][Full Text] [Related]
8. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences.
Campbell RM; Stricker P; Miller R; Bongers J; Liu W; Lambros T; Ahmad M; Felix AM; Heimer EP
Peptides; 1994; 15(3):489-95. PubMed ID: 7937325
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vivo [corrected] biological activity of new agmatine analogs of growth hormone-releasing hormone (GH-RH).
Bokser L; Zarandi M; Schally AV
Life Sci; 1990; 46(14):999-1005. PubMed ID: 2109164
[TBL] [Abstract][Full Text] [Related]
10. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
Felix AM; Lu YA; Campbell RM
Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
[TBL] [Abstract][Full Text] [Related]
11. Response of growth hormone release to human growth hormone-releasing factor and its analogs in the bovine.
Hodate K; Johke T; Ohashi S
Endocrinol Jpn; 1986 Aug; 33(4):519-25. PubMed ID: 3098550
[TBL] [Abstract][Full Text] [Related]
12. GRF analogs and fragments: correlation between receptor binding, activity and structure.
Campbell RM; Lee Y; Rivier J; Heimer EP; Felix AM; Mowles TF
Peptides; 1991; 12(3):569-74. PubMed ID: 1656403
[TBL] [Abstract][Full Text] [Related]
13. Identification of receptor-binding pharmacophores of growth-hormone-releasing factor in rat adenopituitary.
Lefrançois L; Gaudreau P
Neuroendocrinology; 1994 Apr; 59(4):363-70. PubMed ID: 8202217
[TBL] [Abstract][Full Text] [Related]
14. Potent agonists of growth hormone-releasing hormone. Part I.
Zarandi M; Serfozo P; Zsigo J; Bokser L; Janaky T; Olsen DB; Bajusz S; Schally AV
Int J Pept Protein Res; 1992 Mar; 39(3):211-7. PubMed ID: 1399259
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity and conformational analysis of cyclic GRF analogs.
Felix AM; Heimer EP; Wang CT; Lambros TJ; Fournier A; Mowles TF; Maines S; Campbell RM; Wegrzynski BB; Toome V
Int J Pept Protein Res; 1988 Dec; 32(6):441-54. PubMed ID: 3149952
[TBL] [Abstract][Full Text] [Related]
16. Effect of human growth hormone-releasing factor and a potent analog on antibody formation in African green monkeys.
Mowles TF; Stricker P; Felix AM; Soike KF; Campbell RM
Horm Metab Res; 1991 Nov; 23(11):530-4. PubMed ID: 1816063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1.
Ling N; Baird A; Wehrenberg WB; Ueno N; Munegumi T; Chiang TC; Regno M; Brazeau P
Biochem Biophys Res Commun; 1984 Jul; 122(1):304-10. PubMed ID: 6430292
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid.
Sato K; Hotta M; Kageyama J; Chiang TC; Hu HY; Dong MH; Ling N
Biochem Biophys Res Commun; 1987 Dec; 149(2):531-7. PubMed ID: 3122736
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro and in vivo activity of analogs of growth hormone-releasing hormone (GH-RH) with C-terminal agmatine.
Zarandi M; Csernus V; Bokser L; Bajusz S; Groot K; Schally AV
Int J Pept Protein Res; 1990 Dec; 36(6):499-505. PubMed ID: 2090641
[TBL] [Abstract][Full Text] [Related]
20. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Replacement of asparagine residues by serine stabilizes.
Friedman AR; Ichhpurani AK; Brown DM; Hillman RM; Krabill LF; Martin RA; Zurcher-Neely HA; Guido DM
Int J Pept Protein Res; 1991 Jan; 37(1):14-20. PubMed ID: 1904406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
